title: Fatal case of enterovirus 71 infection and rituximab therapy, france, 2012.
authors.forename: Somar
authors.initials: S
authors.lastname: Kassab
authors.forename: Tahar
authors.initials: T
authors.lastname: Saghi
authors.forename: Alexandre
authors.initials: A
authors.lastname: Boyer
authors.forename: Marie-Edith
authors.initials: ME
authors.lastname: Lafon
authors.forename: Didier
authors.initials: D
authors.lastname: Gruson
authors.forename: Bruno
authors.initials: B
authors.lastname: Lina
authors.forename: Hervé
authors.initials: H
authors.lastname: Fleury
authors.forename: Isabelle
authors.initials: I
authors.lastname: Schuffenecker
mesh_terms: D000368:Aged; D058846:Antibodies, Monoclonal, Murine-Derived / Q000008:administration & dosage / Q000009:adverse effects*; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D018792:Encephalitis, Viral / Q000175:diagnosis* / Q000276:immunology / Q000821:virology; D029821:Enterovirus A, Human; D004769:Enterovirus Infections / Q000175:diagnosis* / Q000276:immunology / Q000821:virology; D017809:Fatal Outcome; D005260:Female; D005602:France; D006801:Humans; D016867:Immunocompromised Host; D008224:Lymphoma, Follicular / Q000188:drug therapy; D060046:Maintenance Chemotherapy; D000069283:Rituximab
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000069283:Rituximab
keywords: EV-71; France; enterovirus 71; fatal case; rhomboencephalitis; rituximab; viruses